|
SARS-CoV-2&Respiratory Syncytial Virus&Flu A &Flu B Antigen Rapid Test Cassette (Colloidal Gold)
Respiratory testing often requires multiple targets and specimen types to be managed under one procurement item. This cassette is listed with four antigen targets and three swab specimen categories for professional workflows.
Rapid respiratory antigen testing typically sits close to patient intake, where specimen collection and result turnaround shape clinical decisions. The Guoke Medical cassette is listed for professional medical, diagnostic, or laboratory workflows, not home use.
Its stated function is qualitative detection of SARS-CoV-2, respiratory syncytial virus, influenza A, and influenza B antigens. It uses the rapid immunochromatographic method and accepts nasopharyngeal, oropharyngeal, and nasal swab specimens.
The supplier states the result is intended to give clinicians information for prescribing correct medications. That places the cassette within a broader diagnostic pathway, not as a standalone record of infection or treatment decision.
Procurement details include product code GKPD028 and box configurations of 1, 10, 20, 25, 40, or 50 tests. Buyers should confirm which configuration matches their testing volume and specimen mix.
Because pack size, availability, documentation, MOQ, lead time, and shipping are quote-based, purchase planning should begin with those terms rather than assuming shelf stock.
Verify regulatory status, approved specimen types, storage conditions, kit contents, and labelling claims with the supplier. These determine whether the cassette fits a specific laboratory or clinical protocol.
For multi-pathogen seasons, a four-target cassette may reduce separate line items, but the operational gain depends on validation, workflow fit, and dependable supply.
Why it matters:
Buyers should treat the listed targets and specimen types as the starting point for verification, not as a complete procurement approval.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
ScientificChina is an independent commercial platform and is not affiliated with or endorsed by any Chinese government agency or public institution.
|
|